Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Viral Vector Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Viral Vector Vaccinesmarket, defines the market attractiveness level of Viral Vector Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Viral Vector Vaccines industry, describes the types of Viral Vector Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Viral Vector Vaccines market and the development prospects and opportunities of Viral Vector Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Viral Vector Vaccines market in Chapter 13.
By Player:
Pfizer
Boehringer Ingelheim
Creative Biogene
Brammer Bio
GE Healthcare
Sanofi
Advanced Bioscience Laboratories
By Type:
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Viral Vector Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Viral Vector Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Viral Vector Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Viral Vector Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Viral Vector Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Viral Vector Vaccines Consumption (2017-2022)
-
7.2 United States Viral Vector Vaccines Consumption (2017-2022)
-
7.3 Europe Viral Vector Vaccines Consumption (2017-2022)
-
7.4 China Viral Vector Vaccines Consumption (2017-2022)
-
7.5 Japan Viral Vector Vaccines Consumption (2017-2022)
-
7.6 India Viral Vector Vaccines Consumption (2017-2022)
-
7.7 South Korea Viral Vector Vaccines Consumption (2017-2022)
8 Region and Country-wise Viral Vector Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.4 China Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.6 India Viral Vector Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Viral Vector Vaccines Consumption Forecast (2022-2028)
9 Global Viral Vector Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Viral Vector Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adenovirus Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fowlpox Virus Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Attenuated Yellow Fever Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Vaccinia Virus Vectors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Viral Vector Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Viral Vector Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Viral Vector Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fowlpox Virus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Attenuated Yellow Fever Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Vaccinia Virus Vectors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Viral Vector Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Viral Vector Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Viral Vector Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Viral Vector Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Viral Vector Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Viral Vector Vaccines Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Viral Vector Vaccines Product and Service
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Details
-
14.2.2 Boehringer Ingelheim Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim Viral Vector Vaccines Product and Service
-
14.3 Creative Biogene
-
14.3.1 Creative Biogene Company Details
-
14.3.2 Creative Biogene Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Creative Biogene Viral Vector Vaccines Product and Service
-
14.4 Brammer Bio
-
14.4.1 Brammer Bio Company Details
-
14.4.2 Brammer Bio Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Brammer Bio Viral Vector Vaccines Product and Service
-
14.5 GE Healthcare
-
14.5.1 GE Healthcare Company Details
-
14.5.2 GE Healthcare Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GE Healthcare Viral Vector Vaccines Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Viral Vector Vaccines Product and Service
-
14.7 Advanced Bioscience Laboratories
-
14.7.1 Advanced Bioscience Laboratories Company Details
-
14.7.2 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Advanced Bioscience Laboratories Viral Vector Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Viral Vector Vaccines
-
Figure Viral Vector Vaccines Picture
-
Table Global Viral Vector Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Vector Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Vector Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Viral Vector Vaccines Consumption by Country (2017-2022)
-
Figure United States Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Viral Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Vector Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Viral Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenovirus Consumption and Growth Rate (2017-2022)
-
Figure Global Fowlpox Virus Consumption and Growth Rate (2017-2022)
-
Figure Global Attenuated Yellow Fever Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccinia Virus Vectors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fowlpox Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attenuated Yellow Fever Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccinia Virus Vectors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Viral Vector Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Viral Vector Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Viral Vector Vaccines Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Viral Vector Vaccines Product and Service
-
Table Creative Biogene (Foundation Year, Company Profile and etc.)
-
Table Creative Biogene Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Creative Biogene Viral Vector Vaccines Product and Service
-
Table Brammer Bio (Foundation Year, Company Profile and etc.)
-
Table Brammer Bio Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Brammer Bio Viral Vector Vaccines Product and Service
-
Table GE Healthcare (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Viral Vector Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Viral Vector Vaccines Product and Service
-
Table Advanced Bioscience Laboratories (Foundation Year, Company Profile and etc.)
-
Table Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Bioscience Laboratories Viral Vector Vaccines Product and Service
-
